A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
RemeGen Co., Ltd.
Ruijin Hospital
Ruijin Hospital
Hutchmed
University of Birmingham
Sichuan Provincial People's Hospital
Velindre NHS Trust
State Key Laboratory of Cancer Biology
Shandong Cancer Hospital and Institute
Medical Research Council
Ruijin Hospital
Fudan University
National Cancer Institute (NCI)
Wales Cancer Trials Unit
Fudan University
Peking Union Medical College Hospital
Fudan University